Hawaiʻi Bans Intoxicating Hemp Products Statewide

Emergency Order Shuts Down Hemp-Derived THC Market

The Hawaiʻi Department of Health issued an emergency order September 14 prohibiting the sale, distribution, and possession for sale of any hemp product intended to induce intoxication. The directive applies to delta-8 THC, delta-9 THC derived from hemp, delta-10 THC, THC-O, HHC, and similar synthetic or semi-synthetic cannabinoids extracted from industrial hemp.

Retailers got no grace period. The order takes effect immediately, requiring stores to pull products by close of business September 14. Violations carry penalties under Hawaiʻi Revised Statutes § 329D, the state's hemp regulatory framework, which authorizes fines up to $10,000 per violation and license suspension.

Federal Loophole Drove Unregulated Market Growth

The 2018 Farm Bill legalized hemp containing less than 0.3% delta-9 THC by dry weight, but manufacturers exploited the statute by converting legal CBD into intoxicating isomers. Delta-8 THC and similar compounds occur naturally in trace amounts but get commercially synthesized from CBD isolate through chemical isomerization.

Hawaiʻi's unregulated hemp market grew fast after 2021. Gas stations, convenience stores, and smoke shops sold gummies, vapes, and tinctures labeled as "hemp-derived" but delivering psychoactive effects comparable to cannabis. The products bypassed state testing, labeling, and taxation requirements that govern licensed medical and adult-use cannabis.

The state's action mirrors enforcement trends in 15 other states that have closed the hemp-THC loophole since 2024, including Oregon, Colorado, and New York.

Licensed Cannabis Operators Pushed for Crackdown

Hawaiʻi's licensed medical cannabis dispensaries and adult-use applicants lobbied state officials for months to address what they described as unfair competition from untested hemp products. Licensed operators pay application fees, testing costs, and excise taxes while complying with seed-to-sale tracking and potency limits.

Hemp retailers faced no such requirements. Products frequently contained unlabeled contaminants, including residual solvents and heavy metals, according to third-party lab tests commissioned by advocacy groups. The price gap was stark: licensed cannabis flower averaged $45 per eighth, while hemp-derived delta-8 gummies sold for $15 per 500mg package at convenience stores.

Enforcement Mechanism and Retailer Compliance

The Department of Health will conduct spot inspections at retail locations statewide beginning September 15, targeting known hemp product vendors. Inspectors can seize non-compliant inventory and issue citations on-site. Retailers who comply by removing products before inspection avoid penalties.

Consumer possession isn't criminalized. Individuals holding previously purchased hemp products face no legal consequences, but retailers can't accept returns or offer refunds for seized inventory. The state hasn't announced a buyback or amnesty program.

What Operators Should Watch Next

The immediate question is whether Hawaiʻi will formalize the ban through administrative rulemaking or emergency legislation. Emergency orders under § 329D remain effective for 120 days unless extended by the governor or codified by the legislature. The 2027 legislative session convenes in January, giving lawmakers four months to draft permanent restrictions.

Licensed operators should also monitor whether the state extends the ban to low-dose hemp beverages, a category that some manufacturers argue falls outside the "intoxicating" threshold. The order doesn't define intoxication by milligram dosage, leaving room for interpretive disputes.

We'll be watching the January legislative session for permanent codification and any regulatory guidance on dosage thresholds that could affect hemp beverage products.

For full background on this story, see the CannIntel topic hub on Hawaiʻi's hemp crackdown.